Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Lumos Pharma stock
Learn how to easily invest in Lumos Pharma stock.
Lumos Pharma Inc is a biotechnology business based in the US. Lumos Pharma shares (LUMO) are listed on the NASDAQ and all prices are listed in US Dollars. Lumos Pharma employs 32 staff and has a trailing 12-month revenue of around $734,000.
How to buy shares in Lumos Pharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LUMO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Lumos Pharma stock price (NASDAQ: LUMO)Use our graph to track the performance of LUMO stocks over time.
Lumos Pharma shares at a glance
|Latest market close||$9.05|
|52-week range||$6.15 - $10.58|
|50-day moving average||$8.49|
|200-day moving average||$8.33|
|Wall St. target price||$23.33|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-3.54|
Buy Lumos Pharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Lumos Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Lumos Pharma price performance over time
|1 week (2022-09-27)||0.56%|
|1 month (2022-09-02)||7.74%|
|3 months (2022-07-01)||17.69%|
|6 months (2022-04-04)||4.26%|
|1 year (2021-10-04)||-1.95%|
|2 years (2020-10-02)||-33.50%|
|3 years (2019-10-04)||647.93%|
|5 years (2017-10-04)||11.87|
Lumos Pharma financials
|Gross profit TTM||$230,000|
|Return on assets TTM||-18.6%|
|Return on equity TTM||-32.67%|
|Market capitalisation||$74.8 million|
TTM: trailing 12 months
Lumos Pharma share dividends
We're not expecting Lumos Pharma to pay a dividend over the next 12 months.
Have Lumos Pharma's shares ever split?
Lumos Pharma's shares were split on a 1:9 basis on 18 March 2020. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Lumos Pharma shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for Lumos Pharma shares which in turn could have impacted Lumos Pharma's share price.
Lumos Pharma share price volatility
Over the last 12 months, Lumos Pharma's shares have ranged in value from as little as $6.15 up to $10.58. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lumos Pharma's is 0.8583. This would suggest that Lumos Pharma's shares are less volatile than average (for this exchange).
Lumos Pharma overview
Lumos Pharma, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas. .
Lumos Pharma in the news
Lumos Pharma to Participate in the Cantor Neurology & Psychiatry Conference
Frequently asked questionsWhat percentage of Lumos Pharma is owned by insiders or institutions?
Currently 33.353% of Lumos Pharma shares are held by insiders and 28.649% by institutions. How many people work for Lumos Pharma?
Latest data suggests 32 work at Lumos Pharma. When does the fiscal year end for Lumos Pharma?
Lumos Pharma's fiscal year ends in December. Where is Lumos Pharma based?
Lumos Pharma's address is: 4200 Marathon Boulevard, Austin, TX, United States, 78756 What is Lumos Pharma's ISIN number?
Lumos Pharma's international securities identification number is: US55028X1090 What is Lumos Pharma's CUSIP number?
Lumos Pharma's Committee on Uniform Securities Identification Procedures number is: 55028X109
More guides on Finder
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert